# The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children

> **NCT07424040** · NA · NOT_YET_RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 154 (estimated)

## Conditions studied

- Crohn's Diseases
- Crohn's Disease in Pediatric Patient

## Interventions

- **DRUG:** Infliximab combined with azathioprine therapy
- **DRUG:** Infliximab monotherapy

## Key facts

- **NCT ID:** NCT07424040
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07424040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07424040, "The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07424040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*